Shandong Suncadia Medicine Co., Ltd.
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for Postoperative analgesia in orthopaedics. To explore the reasonable dosage of HRS-2129 for Postoperative analgesia in orthopaedics.
Postoperative Pain in Orthopaedics
HRS-2129
HRS-2129
HRS-2129 placebo
PHASE1
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 40 participants |
Masking : | QUADRUPLE |
Primary Purpose : | TREATMENT |
Official Title : | Clinical Study on Safety and Efficacy of HRS-2129 for Postoperative Analgesiain Orthopaedics |
Actual Study Start Date : | 2025-02-15 |
Estimated Primary Completion Date : | 2025-06-30 |
Estimated Study Completion Date : | 2025-06-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610072